Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Cannabis and Cannabinoid Research
|
May 16, 2026
<b>Quantification of 14 Major and Minor Cannabinoids with Absorbance</b>-<b>Transmittance Excitation</b>-<b>Emission Matrix Spectroscopy and Machine Learning</b>
Mostafa A Elhendawy, Adam M Gilmore, Mohamed M Radwan, et al.
Bioorganic Chemistry
|
June 27, 2021
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation
Khaled El-Adl, Helmy M Sakr, Reda G Yousef, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 24, 2022
Discovery of new 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as anticancer agents targeting EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>
Ahmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Bioorganic Chemistry
|
December 9, 2019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
Hazem A Mahdy, Mohammed K Ibrahim, Ahmed M Metwaly, et al.
Bioorganic Chemistry
|
October 31, 2020
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation
Ibrahim H Eissa, Abdel-Ghany A El-Helby, Hazem A Mahdy, et al.
Bioorganic Chemistry
|
September 4, 2020
Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors
Abdel-Ghany A El-Helby, Helmy Sakr, Rezk R Ayyad, et al.
Bioorganic & Medicinal Chemistry
|
November 20, 2020
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors
Khaled El-Adl, Abdel-Ghany A El-Helby, Rezk R Ayyad, et al.
Archiv Der Pharmazie
|
August 30, 2019
Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors
Ibrahim H Eissa, Ahmed M Metwaly, Amany Belal, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Cannabis and Cannabinoid Research
|
May 16, 2026
<b>Quantification of 14 Major and Minor Cannabinoids with Absorbance</b>-<b>Transmittance Excitation</b>-<b>Emission Matrix Spectroscopy and Machine Learning</b>
Mostafa A Elhendawy, Adam M Gilmore, Mohamed M Radwan, et al.
Bioorganic Chemistry
|
June 27, 2021
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation
Khaled El-Adl, Helmy M Sakr, Reda G Yousef, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 24, 2022
Discovery of new 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as anticancer agents targeting EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>
Ahmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Bioorganic Chemistry
|
December 9, 2019
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
Hazem A Mahdy, Mohammed K Ibrahim, Ahmed M Metwaly, et al.
Bioorganic Chemistry
|
October 31, 2020
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation
Ibrahim H Eissa, Abdel-Ghany A El-Helby, Hazem A Mahdy, et al.
Bioorganic Chemistry
|
September 4, 2020
Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors
Abdel-Ghany A El-Helby, Helmy Sakr, Rezk R Ayyad, et al.
Bioorganic & Medicinal Chemistry
|
November 20, 2020
Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors
Khaled El-Adl, Abdel-Ghany A El-Helby, Rezk R Ayyad, et al.
Archiv Der Pharmazie
|
August 30, 2019
Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors
Ibrahim H Eissa, Ahmed M Metwaly, Amany Belal, et al.
Page
of 2